Trial Profile
A Phase 4 Safety Study of IOP Signals in Patients Treated With ILUVIEN (Fluocinolone Acetonide Intravitreal Implant) 0.19 mg
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Nov 2023
Price :
$35
*
At a glance
- Drugs Fluocinolone acetonide (Primary)
- Indications Diabetic macular oedema
- Focus Adverse reactions
- Acronyms PALADIN
- Sponsors Alimera Sciences
- 31 Oct 2023 According to an Alimera Sciences Media Release, data form this study will be featured in three posters and a presentation during the American Academy of Ophthalmology's 127th Annual Meeting being held in San Francisco from November 3-6, 2023.
- 11 Oct 2023 According to an Alimera Sciences Media Release, data from this study will be presented during the Retina Societys 56th Annual Scientific Meeting being held in New York City.
- 20 Apr 2023 According to an Alimera Sciences media release, company announced four posters will be presented at the annual Association for Research in Vision and Ophthalmology (ARVO) conference which will take place in New Orleans, Louisiana from April 23-27, 2023.